NCT02078063View on ClinicalTrials.gov

Analgesia for Insertion of Intrauterine Contraception

PHASE3CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Insertion of Intrauterine Contraception
Interventions
DRUG

Mepivacaine

10 ml of Mepivacaine for injection (Carbocain®) 10 mg/ml instilled into the uterus through a hydrosonography catheter

DRUG

Placebo

10 ml of NaCl 0.9 mg/ml instilled into the uterus through a hydrosonography catheter

Trial Locations (2)

182 88

Dept of Obstetrics and Gynecology, Danderyd Hospital, Stockholm

Unknown

Upplands Väsby Ungdomsmottagning, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02078063 - Analgesia for Insertion of Intrauterine Contraception | Biotech Hunter | Biotech Hunter